Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children

Leukemia and Lymphoma

Volumn 57, Issue 6, 2016, Pages 1436-1441

  Tong, Na ^a   Chu, Haiyan ^a   Wang, Meilin ^a   Xue, Yao ^a   Du, Mulong ^a   Lu, Lingling ^a   Zhang, Heng ^a   Wang, Feng ^a   Fang, Yongjun ^a   Li, Jie ^b   Wu, Dongmei ^a   Zhang, Zhengdong ^a   Sheng, Xiaojing ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

childhood ALL; genetic susceptibility; miR 34b c; molecular epidemiology; transcription activity

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 34B; MICRORNA 34C; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL EVALUATION; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAN CHINESE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; JURKAT CELL LINE; K562 CELL LINE; LOW RISK PATIENT; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; PAINTING; PARENTAL BEHAVIOR; PARENTAL SMOKING; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSIENT TRANSFECTION; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; ENVIRONMENT; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; ODDS RATIO; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; RISK;

ADOLESCENT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; ENVIRONMENT; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; RISK;

EID: 84946924830     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2015.1092528     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010; 36: 277-285.
3. Terracini B. Epidemiology of childhood cancer. Environ Health 2011; 10 (Suppl. 1): S8.
4. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the childrens oncology group. J Clin Oncol 2012; 30: 1663-1669.
5. C.S.U.W. Group. United States Cancer Statistics: 1999-2010 incidence and mortality Web-based Report. Centers for Disease Control and Prevention, and National Cancer Institute 2013; Available at: http://www.cdc.gov/uscs
6. Weinberg RA. Tumor suppressor genes. Science 1991; 254 (5035): 1138-1146.
7. Studniak E, Maloney E, Ociepa T, et al. Allelic loss of selected tumor suppressor genes in acute lymphoblastic leukemia in children. Pol J Pathol 2013; 64: 121-128.
8. Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
9. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447 (7148): 1130-1134.
10. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
11. Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-Arrest. Cell Cycle 2007; 6: 1586-1593.
12. Li L, Wu J, Sima X, et al. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol 2013; 34: 1919-1923.
13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
14. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007; 104: 3300-3305.
15. Agostini M, Knight RA. miR-34: from bench to bedside. Oncotarget 2014; 5: 872-881.
16. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
17. Son MS, Jang MJ, Jeon YJ, et al. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. Gene 2013; 524: 156-160.
18. Wiggins JF, Ruffino L, Kelnar K, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010; 70: 5923-5930.
19. Xu Y, Liu L, Liu J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 2011; 128: 412-417.
20. Liu YM, Wang Y, Peng W, et al. Single-nucleotide polymorphism of the pri-miR-34b/c gene is not associated with susceptibility to congenital heart disease in the Han Chinese population. Genet Mol Res 2013; 12: 2937-2944.
21. Tong N, Fang Y, Li J, et al. Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci 2010; 101: 782-786.
22. Tong N, Xu B, Shi D, et al. Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children. Mutat Res 2014; 759: 16-21.
23. Han Y, Pu R, Han X, et al. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One 2013; 8 (3): e58564.
24. Oh J, Kim JW, Lee BE, et al. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer. Oncol Rep 2014; 31: 995-1002.
25. Gao LB, Li LJ, Pan XM, et al. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem 2013; 394: 415-420.
26. Zhang S, Qian J, Cao Q, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis 2014; 29: 149-154.
27. Tian Q, Jia J, Ling S, et al. A causal role for circulating miR-34b in osteosarcoma. Eur J Surg Oncol 2014; 40: 67-72.
28. Bensen JT, Tse CK, Nyante SJ, et al. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control 2013; 24: 1099-1109.
29. Li L, Sima X, Bai P, et al. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm. Clin Dev Immunol 2012; 2012: 567586.